Cargando…

MiR‐15a/16‐1 deficiency induces IL‐10‐producing CD19(+) TIM‐1(+) cells in tumor microenvironment

IL‐10‐producing B cells (B10) are associated with autoimmune diseases, infection and tumours. MiR‐15a/16 as a tumour‐suppressive gene is down‐regulated in several tumours, such as chronic lymphocytic leukaemia, pituitary adenomas and prostate carcinoma. Here, increased frequency of IL‐10‐producing C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Xiaoqin, Liu, Hao, Xu, Chong, Han, Sen, Shen, Yating, Miao, Xin, Hu, Xiangyu, Lin, Zhijie, Qian, Li, Wang, Zhengbing, Gong, Weijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349175/ https://www.ncbi.nlm.nih.gov/pubmed/30467955 http://dx.doi.org/10.1111/jcmm.14037

Ejemplares similares

Physics Conference TIM-15-16
Publicado: (2016)

P16-30. Induction of Tim-3 expression by the common gamma-chain cytokines IL-2, IL-7, IL-15 and IL-21
por: Jones, BR, et al.
Publicado: (2009)

MiR‐16 regulates mouse peritoneal macrophage polarization and affects T‐cell activation
por: Jia, Xiaoqin, et al.
Publicado: (2016)

PD-1 and TIM-3 differentially regulate subsets of mouse IL-17A–producing γδ T cells
por: Edwards, Sarah C., et al.
Publicado: (2022)

TIM4-TIM1 interaction modulates Th2 pattern inflammation through enhancing SIRT1 expression
por: Hu, Tianyong, et al.
Publicado: (2017)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

IL-15 is an inflammatory mediator in the tumor microenvironment
por: Anthony, Scott M, et al.
Publicado: (2015)

Tim-1 Deficiency Aggravates High-Fat Diet-Induced Steatohepatitis in Mice
por: George, Jasmine, et al.
Publicado: (2021)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes
por: Liu, Yikai, et al.
Publicado: (2021)

The Mitochondrial Protein Translocation Motor: Structural Conservation between the Human and Yeast Tim14/Pam18-Tim16/Pam16 co-Chaperones
por: Elsner, Shira, et al.
Publicado: (2009)

The Role of TIM-3 and LAG-3 in the Microenvironment and Immunotherapy of Ovarian Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022)

Mitochondrial Tim9 protects Tim10 from degradation by the protease Yme1
por: Spiller, Michael P., et al.
Publicado: (2015)

IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity
por: Rauch, Daniel A, et al.
Publicado: (2014)

IL-15 Deficient Tax Mice Reveal a Role for IL-1α in Tumor Immunity
por: Rauch, Daniel A., et al.
Publicado: (2014)

Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment
por: Li, Jing, et al.
Publicado: (2014)

TIM-1 Augments Cellular Entry of Ebola Virus Species and Mutants, Which Is Blocked by Recombinant TIM-1 Protein
por: Zhang, Min, et al.
Publicado: (2022)

Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer
por: He, Xing, et al.
Publicado: (2023)

Immune Regulation and Antitumor Effect of TIM-1
por: Du, Peng, et al.
Publicado: (2016)

Expression of Tim‐1 in primary CNS lymphoma
por: Kishimoto, Wataru, et al.
Publicado: (2016)

Suppression of Allograft Rejection by Tim-1-Fc through Cross-Linking with a Novel Tim-1 Binding Partner on T Cells
por: Xiao, Liang, et al.
Publicado: (2011)

Interleukin (IL)-15Rα–deficient Natural Killer Cells Survive in Normal but Not IL-15Rα–deficient Mice
por: Koka, Rima, et al.
Publicado: (2003)

Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice
por: Gao, Jie, et al.
Publicado: (2023)

sTim-3 alleviates liver injury via regulation of the immunity microenvironment and autophagy
por: Yang, Ying, et al.
Publicado: (2020)

Kim-1/Tim-1 and Immune cells: Shifting Sands
por: Ichimura, Takaharu, et al.
Publicado: (2012)

TIM-3 and TIM-1 Could Regulate Decidual γδTCR Bright T Cells during Murine Pregnancy
por: Nörenberg, Jasper, et al.
Publicado: (2019)

Tim-3 Negatively Regulates IL-12 Expression by Monocytes in HCV Infection
por: Zhang, Ying, et al.
Publicado: (2011)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Tim Lou
por: Lou, Hou Keong
Publicado: (2009)

Anti‐TIM‐1 Monoclonal Antibody (RMT1‐10) Attenuates Atherosclerosis By Expanding IgM‐producing B1a Cells
por: Hosseini, Hamid, et al.
Publicado: (2018)

Murine Tim-1 is excluded from the immunological synapse
por: Lin, Jean, et al.
Publicado: (2012)

NKG2D-IL-15 fusion protein encapsulated in N-[(2-hydroxy-3-trimethylammonium) propyl] chitosan chloride retards melanoma growth in mice
por: Chen, Rong, et al.
Publicado: (2019)

An IL-27/NFIL3 signaling axis drives Tim-3 and IL-10 expression and T cell dysfunction
por: Zhu, Chen, et al.
Publicado: (2015)

IMMU-08. MICROENVIRONMENT MODULATION BY TIM-3 BLOCKADE IMPROVES THE OUTCOME OF PRECLINICAL DIPG MODELS
por: Ausejo-Mauleon, Iker, et al.
Publicado: (2021)

Immunomodulation with IL-7 and IL-15 in HIV-1 infection
por: Gunst, Jesper D., et al.
Publicado: (2023)

KIM-1/TIM-1 in proximal tubular cell immune response
por: Brooks, Craig R., et al.
Publicado: (2015)

The miR-15a/16-1 and miR-15b/16-2 clusters regulate early B cell development by limiting IL-7 receptor expression
por: Hutter, Katharina, et al.
Publicado: (2022)

TIM-Finder: A new method for identifying TIM-barrel proteins
por: Si, Jing-Na, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h0kabbenfe1aahuif7me3m2f12